| Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion. | |
| | |
MedLine Citation:
|
PMID: 6391746 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The mechanism for the hyperinsulinaemia in cirrhosis was investigated using two different approaches. In the first study, the metabolic clearance rate of insulin was measured at steady state in 13 cirrhotic and 13 weight-matched control subjects. With comparable insulin infusion rates (1.00 +/- 0.19 versus 1.07 +/- 0.15 mU/kg/min), steady-state plasma insulin concentrations (104 +/- 25 versus 87 +/- 12 microU/ml; P greater than 0.5) and MCRIRI (13.6 +/- 1.6 versus 15.4 +/- 2.0 ml/kg/min; P greater than 0.5) were similar. In the second study, fasting and oral glucose stimulated C-peptide/insulin ratios were compared in 16 cirrhotic and 18 weight matched control subjects. Although fasting glucose levels were significantly higher in the cirrhotic groups, all values were in the normal range (5.5 +/- 0.3 versus 4.8 +/- 0.1 mmol/l, P less than 0.02). However, fasting insulin (0.171 +/- 0.02 versus 0.068 +/- 0.004 nmol/l) and C-peptide (1.02 +/- 0.13 versus 0.42 +/- 0.02 nmol/l) were strikingly higher (P less than 0.001) in cirrhotic subjects. On the other hand, fasting C-peptide/insulin ratios were not statistically different in the two groups (6.18 +/- 0.52 versus 6.77 +/- 0.46; P greater than 0.3). This suggests that beta cell hypersecretion was the principal cause of the fasting hyperinsulinaemia, rather than decreased insulin hepatic extraction. Following the glucose load in 13 of the control and seven of the cirrhotic group, the C-peptide/insulin ratio fell in both groups but was significantly lower in the cirrhotic compared to control subjects at 30, 60 and 120 min, consistent with possible impairment of hepatic insulin extraction.(ABSTRACT TRUNCATED AT 250 WORDS) |
| | |
Authors:
|
J Proietto; F J Dudley; P Aitken; F P Alford |
Related Documents
:
|
22707396 - Celiac disease in subjects with type 1 diabetes mellitus: a prevalence study in western... 22533366 - Point-of-care β-hydroxybutyrate measurement for the diagnosis of feline diabetic ketoa... 22434076 - Ampk enhances insulin-stimulated glut4 regulation via lowering membrane cholesterol. 22684266 - Fasting plasma glucose correlates with angiographic coronary artery disease prevalence ... 22237966 - Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats : attenuation of... 15301226 - Metabolic syndrome. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Clinical endocrinology Volume: 21 ISSN: 0300-0664 ISO Abbreviation: Clin. Endocrinol. (Oxf) Publication Date: 1984 Dec |
Date Detail:
|
Created Date: 1985-02-11 Completed Date: 1985-02-11 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0346653 Medline TA: Clin Endocrinol (Oxf) Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 657-65 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Blood Glucose / metabolism C-Peptide / blood Fasting Female Glucose Tolerance Test Humans Insulin / blood*, secretion Insulin Resistance* Islets of Langerhans / secretion Liver Cirrhosis / blood*, physiopathology Male Metabolic Clearance Rate Middle Aged |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/C-Peptide; 11061-68-0/Insulin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of sodium salicylate on hormonal responses to hypoglycaemia in type II diabetics.
Next Document: Insulin resistance in cirrhosis: evidence for a post-receptor defect.